UCSF

Dear Research Advocate, “We are in the profession that aims to come up with answers. We have a mission and a noble one. I often like to point out while our initials are NIH….in circumstances like this we’re the National Institutes of Hope. While fear, anxiety, and stress are all around us, hope can be contagious.” —Francis Collins, MD, PhD Earlier today, Dr. Francis Collins, Director of the National Institutes of Health (NIH), joined us on our alliance member call to provide an overview of NIH’s unprecedented Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) , a partnership between industry and governmental leaders working to speed COVID-19 vaccines and treatments. Dr...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
By Dai Horiuchi, PhD and Bradley Webb, PhD, co-leaders of the Science Advocacy Subgroup and organizing members of the Science Policy Group at the University of California, San Francisco (a Research!America member). The Science Policy Group (SPG) at the University of California, San Francisco (UCSF) is determined to take advantage of this crisis situation brought about by the sequester to speak up for the future of academic biomedical science in America. We’€™re composed of a dedicated group of life sciences graduate students and postdoctoral scholars. Our primary mission is to educate ourselves as well as the general public about policy issues and to take actions for the advancement of...
By Dai Horiuchi, PhD and Bradley Webb, PhD, co-leaders of the Science Advocacy Subgroup and organizing members of the Science Policy Group at the University of California, San Francisco (a Research!America member). The Science Policy Group (SPG) at the University of California, San Francisco (UCSF) is determined to take advantage of this crisis situation brought about by the sequester to speak up for the future of academic biomedical science in America. We’€™re composed of a dedicated group of life sciences graduate students and postdoctoral scholars. Our primary mission is to educate ourselves as well as the general public about policy issues and to take actions for the advancement of...
Dear Research Advocate, “2013 is a bad year to have a good idea,” was the bleak statement Laura Niedernhofer, MD, PhD, made about the impact of sequestration in a recent FASEB report . None of us want this year, or this country, to be a bad starting point for good ideas ’€¦ but that’s what’s at stake. Think about telling someone with a serious illness that this isn’t a good year, or a good decade, for research. Think about telling them that from here on out, it may always be a bad year for a good idea. Is there hope for turning this around? We have bipartisan support and we have champions; that we need more is a reality, but by no means an impossibility. Cancer research advocates gathered...
The Albert and Mary Lasker Foundation has announced the winners of its 2012 Awards : Albert Lasker Basic Medical Research Award: Michael Sheetz, PhD (Columbia University); James Spudich, PhD (Stanford University); and Ronald Vale, PhD (University of California San Francisco) Lasker~DeBakey Clinical Medical Research Award: Sir Roy Calne (University of Cambridge, emeritus); Thomas E. Starzl, MD, PhD (University of Pittsburgh) Lasker~Koshland Special Achievement Award: Donald D. Brown, DSc (Carnegie Institute); Tom Maniatis, PhD (Columbia University) The winners were announced Monday. The seven men will be honored at a ceremony September 21 in New York. “The Lasker Awards celebrate biomedical...

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter